trial · primary record
Niraparib
Prostatic Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 136 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Maximum Observed Analyte Concentration at Steady State (Cmax,ss) of Niraparib and Abiraterone Acetate (AA) [Period 2 and Period 3] |
| Registry ID | NCT04577833 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:08.276Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04577833
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Niraparib · compound